Plant Based Biomanufacturing Market to Grow with an Impressive CAGR During the Forecast Period
Advancing
technology in botanical medicine is driving the growth in Global Plant Based
Biomanufacturing Market in the forecast period, 2022-2026.
According to TechSci Research report, “Global Plant
Based Biomanufacturing Market
By Product Type (Antibodies, Vaccines, Proteins, Biologics, Enzyme, Others) By
Technology (Upstream v/s Downstream) By Source (Whole Plant, Plant Cells, Seed,
Leaf, Others) By End User (Biotechnology & Pharmaceutical Companies,
Contract Manufacturing Organizations, Others) By Region, Competition Forecast
& Opportunities, 2026”, the global plant
based biomanufacturing market may potentially project an impressive growth in
the forecast period, 2022-2026, with an impressive CAGR on the account of rising
demand for food and beverages containing organic and herbal ingredient. Surging
demand from the health-conscious consumers has driven the biotechnological research
to be dedicated toward finding such product. Number of biotechnological studies
and research institutes are rapidly increasing and thus driving the growth of
the global plant based biomanufacturing market in the upcoming five years.
Increasing number of upcoming plant-based proteins and development in the
studies of recombinant protein that are plant based, is also supporting the
growth of the global plant based biomanufacturing market in the next five
years.
Plant based biomanufacturing includes protein
manufacturing processes through recombinant protein production. These proteins
include protein biopolymers, industrial proteins and enzymes, and therapeutic
proteins. The production processes involve a narrowing diversity of bioreactors
for cell, hairy root, microalgae, and moss cultivation. Direct use of
cultivated plant cells, whole or minimally processed plants, or plant parts
(e.g., seeds, dried leaves) is in development for industrial/bioenergy
applications as well as for therapeutics and vaccines and play a vital role in
bio-pharmaceutical productions.
Browse over XX
market data Figures spread through 110 Pages
and an in-depth TOC on " Global Plant based
biomanufacturing Market"
https://www.techsciresearch.com/report/plant-based-biomanufacturing-market/7734.html
The global plant based biomanufacturing is
segmented by product type, technology, source, end user, competitional
landscape, and regional distribution. Based on technology, the market is
further divided between upstream biomanufacturing and downstream
biomanufacturing. Upstream biomanufacturing is the process of growing protein
products by either bacterial culture of cell culture. Plant cells if used for
these cultures are termed as upstream plant based biomanufacturing. These
manufactured proteins are specifically laboratory designed to combat various
kind of diseases. In the upstream biomanufacturing processes, the biological
materials are obtained from outside source or inoculated and grown in culture,
under controlled conditions. In the downstream biomanufacturing process the
biological products are harvested, tested, purified, and packaged. Plant-based
biomanufacturing depending on the recombinant protein processes can either be
done through upstream or downstream technology. The advantages of these
biotechnological processes is anticipated to drive the growth of the global
plant based biomanufacturing market in the upcoming five years.
Based on product type, the market is further
bifurcated into antibodies, vaccines, proteins, biologics, enzyme, and others.
Biologics are anticipated to hold the largest revenue shares of the market and
dominate the segment in the next five years on the account of changing consumer
preferences to more nutritional and herbal products. Consistent research and
advancing plant based medicinal nutrient is also driving the growth of the
global plant based biomanufacturing market in the upcoming five years. Vaccines
are expected to show fastest growing CAGR in the next five years on the account
of rapidly evolving drug development procedures that have plant based
recombinant proteins. Also, the recent pandemic situation due to COVID-19 has
enhanced the healthcare industry inclination toward finding plant based
vaccines for the protection against deadly viruses. These factors are actively
influencing the growth of the global plant based biomanufacturing market in the
future five years of forecast until 2026.
Holding the major shares of the global plant based
biomanufacturing market are Pfizer, Inc., Aimmune Therapeutics Inc. (Nestle),
Medicago, Inc., Kentucky BioProcessing, Inc., iBio, Inc., PlantForm
Corporation, Ventria Bioscience Inc., Protalix Biotherapeutics, Inc., Planet
Biotechnology Inc., Zea Biosciences Corp., among others. Market players are
actively involved in the research and technological development in the product
developments. The advanced technology has made it possible for the industry to
provide excellent services through plant based biomanufacturing. Further
advancement would aid the market value and brand establishment in the future
five years. New market players may focus on the research and development to
provide options that satisfies the consumer demand as well as benefits the
market players in building their brand value. Other competitive strategies
include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7734
Customers can also request for
10% free customization on this report.
“Asia Pacific region is
expected to register a substantial growth with the fastest growing CAGR on the
account of rapidly increasing biotechnological research in the countries like
India, China, South Korea, and China. The evolution of medical, healthcare, and
botanical sciences is also apprehensive of the future growth of the global
plant based biomanufacturing market. New drug development, effective
diagnostics, nutrient based food are some of the major products of plant based
biomanufacturing that will enhance the growth mapping of the market. Consistent
research and technological advancement may support the new market players
trying to enter the market in the future five years and in their brand
establishment,” said Mr. Karan Chechi, Research Director with TechSci Research,
a research based Global management consulting firm.
“Global Plant Based
Biomanufacturing Market By Product Type (Antibodies, Vaccines, Proteins,
Biologics, Enzyme, Others) By Technology (Upstream v/s Downstream) By Source
(Whole Plant, Plant Cells, Seed, Leaf, Others) By End User (Biotechnology &
Pharmaceutical Companies, Contract Manufacturing Organizations, Others) By
Region, Competition Forecast & Opportunities, 2026”, has evaluated the
future growth potential of global plant based biomanufacturing and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers, challenges,
and opportunities in global plant based biomanufacturing market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/